(G020) Development and reporting of an enhanced polygenic risk score clinical assay for 8 cardiometabolic conditions

Friday, November 14, 2025

9:15 AM - 10:15 AM EST

Speaker(s)

Matthew Lebo, PhD (he/him/his)

Chief Laboratory Director
Lab for Molecular Medicine, Mass General Brigham Personalized Medicine
Cambridge, Massachusetts, United States